D. Georgiadis et al., INTRACRANIAL MICROEMBOLIC SIGNALS IN 500 PATIENTS WITH POTENTIAL CARDIAC OR CAROTID EMBOLIC SOURCE AND IN NORMAL CONTROLS, Stroke, 28(6), 1997, pp. 1203-1207
Background and Purpose We undertook this study to evaluate the prevale
nce and clinical correlations of Doppler microembolic signals (MES) in
stroke-prone patients. Methods Patients with potential cardiac (n=300
) or carotid (n=100) embolic source and control subjects (n=100) were
monitored with transcranial Doppler sonography for MES. Transthoracic
(n=192) and/or transesophageal (n=134) echocardiography and carotid st
udies (continuous-wave Doppler, n=181; color-coded duplex, n=47) were
performed in all patients with potential native cardioembolic source.
Carotid disease was evaluated by means of continuous-wave Doppler (n=8
7), color-coded duplex (n=70), or intra-arterial angiography (n=24) in
patients with potential carotid embolic source. Results Overall MES p
revalence was 23% in patients with potential native cardioembolic sour
ce (infective endocarditis [n=7] 43%, left ventricular aneurysm [n=38]
34%, intracardiac thrombus [n=23] 26%, dilative cardiomyopathy [n=39]
26%, nonvalvular atrial fibrillation [n=24] 21%, valvular disease [n=
80] 15%), 55% in patients with prosthetic cardiac valves (mechanical [
n=77] 58%, porcine [n=7] 43%, homografts [n=5] 20%), 28% in patients w
ith carotid disease (symptomatic [n=46] 52%, asymptomatic [n=54] 7%; P
<.01), and 5% in control subjects. No relationship between MES counts
and patients' age, sex, or actual medication was noted. The sensitivit
y and specificity of MES detection in identifying patients with potent
ial embolic sources were 31% and 95%, respectively. Conclusions Our st
udy confirmed the reported clinical significance of MES in patients wi
th carotid disease and the high specificity of this technique. The dem
onstrated low sensitivity of MES detection could be due to short monit
oring duration or application of antihemostatic treatment. Prospective
large-scale studies are needed to determine the definitive value of M
ES detection as a diagnostic method in patients with potential cardioe
mbolic source.